Type I IFN response was impaired in severe and critical COVID-19 patients: striking downregulation of ISGs, IRF-1 and STAT3, absence of circulating IFN-β in patients with all disease-severity grades and low IFN-α production in severe COVID-19 patients were reported [TE90]. This evidence concerns the gene IFNA1 and COVID-19.